US20020026238A1 - Heart valve having tissue alignment with anchors and an outer sheath - Google Patents

Heart valve having tissue alignment with anchors and an outer sheath Download PDF

Info

Publication number
US20020026238A1
US20020026238A1 US09/982,609 US98260901A US2002026238A1 US 20020026238 A1 US20020026238 A1 US 20020026238A1 US 98260901 A US98260901 A US 98260901A US 2002026238 A1 US2002026238 A1 US 2002026238A1
Authority
US
United States
Prior art keywords
tissue
leaflets
frame
anchors
heart valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/982,609
Inventor
Ernest Lane
David Tompkins
David Hemsley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/982,609 priority Critical patent/US20020026238A1/en
Publication of US20020026238A1 publication Critical patent/US20020026238A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409Support rings therefor, e.g. for connecting valves to tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415Manufacturing methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable

Definitions

  • This invention relates to improvements in heart valves using autologous tissue held in place by anchors and an outer sheath.
  • the heart valve can be constructed intraoperatively within a short time, typically 10 minutes.
  • One form of heart valve is constructed from animal tissue, typically from bovine or porcine aortic valve tissue. These valves must typically be constructed in a laboratory well in advance of when they will be needed and then stored in an aldehyde solution. Skilled technicians are required to assemble these valves.
  • the valves constructed from animal tissue have relatively short lifetimes. The short lifetimes are caused by two factors. First, there is an antigenic reaction by the body to the animal tissue which causes the tissue to calcify, making it inflexible and more susceptible to failure with time. Second, the tissue is often stored in glutaraldehyde before implantation to try to decrease the antigenic reaction. The aldehyde tends to tan the tissue to a leather-like consistency, which makes it wear out from the repeated stress of opening and closing.
  • Mechanical heart valves are also available. These valves are made from hard, non-biological materials such as metals or ceramics. Although the mechanical heart valves are durable, the hard, non-biological surfaces on the valves tend to cause blood clots. The blood clots can cause heart attacks or strokes, and, as a result, patients with mechanical heart valves must take anticoagulant drugs. These drugs can lead to hemorrhagic complications. Also, patients on these drugs require frequent and life-long laboratory tests of their clotting time.
  • Another type of heart valve is constructed with the patient's own tissue.
  • a number of patents for autologous tissue heart valves and methods of making autologous tissue heart valves have issued to Autogenics, assignee of this application, including U.S. Pat. Nos. 5,161,955 and 5,326,371.
  • the preferred embodiments provide improved apparatus and methods for constructing an autologous heart valve.
  • a significant factor is that both the configuration of the autologous tissue and its means for attachment to the frame of the valve prevent deleterious stress on the tissue.
  • pericardium tissue taken from the patient into three separate tissue leaflets, each generally semi-circular shape and having a plurality of tissue anchor holes located along a tissue cusp line. The location of these tissue anchor holes correspond to tissue anchor hooks permanently attached to a tissue mounting frame.
  • a significant feature is that the manner in which the autologous tissue is supported prevents deterioration stress on the tissue.
  • the tissue is thus not clamped between two unyielding members, but rather supported and retained by the combination of anchors mated in tissue anchor holes and the elastomeric sheath engaging a peripheral portion of the tissue leaflets between the elastomeric sheath member and the inner tissue mounting frame.
  • tissue leaflets are formed to include sufficient extra tissue area to provide a physiologically representative coaptation line angle to thereby reduce the stretch in the tissue held in place by the sheath and thus further reduce the stress in the tissue.
  • FIG. 1 is a perspective view of a preferred embodiment of an assembled autologous heart valve constructed in accordance with preferred methods
  • FIG. 2A is a front view during manufacture of the inner frame portion of the tissue mounting frame
  • FIG. 2B is a front view during manufacture of the outer frame portion of the tissue mounting frame
  • FIG. 3A is a perspective view of the outer frame after it has been rolled into a cylindrical configuration
  • FIG. 3B is a perspective view of the inner and outer frames concentrically joined together
  • FIG. 3C is a perspective of the completed tissue mounting frame with tissue anchors before it is covered with cloth;
  • FIG. 3D is an enlarged perspective view showing one of the commissure post anchors
  • FIG. 4 is an enlarged view of the commissure tissue anchors
  • FIG. 5 is an enlarged view of the cusp tissue anchor ;
  • FIG. 6 is a cross-sectional view taken along line 6 - 6 of FIG. 3C;
  • FIG. 7A is a front view of one of the autologous tissue leaflets
  • FIG. 7B is a front view of the autologous tissue leaflet of FIG. 7A, showing the excess tissue for overlap of the tissue leaflets on the commissure hooks;
  • FIG. 8 is the cross-sectional view of FIG. 6 with the addition of two overlapping autologous tissue leaflets
  • FIG. 9A is a perspective view of the elastomeric sheath
  • FIG. 9B is a cross-sectional view taken along line 9 B- 9 B of FIG. 9A;
  • FIG. 10A is a perspective view of the elastomeric sheath attached to the tissue mounting frame
  • FIG. 10B is a front view of the elastomeric sheath shown in FIG. 10A;
  • FIG. 10C is a sectional view taken along line 10 C- 10 C of FIG. 1;
  • FIG. 11A is a sectional view taken along line 11 A- 11 A of FIG. 1;
  • FIG. 11B is a cross-sectional view of line 11 B- 11 B of FIG. 1;
  • FIG. 11C is a cross-sectional view of line 11 C- 11 C of FIG. 1;
  • FIG. 12A is a perspective view of the annular sewing ring before it is covered with cloth;
  • FIG. 12B is a cross-sectional view taken along line 12 B- 12 B of FIG. 12A.
  • FIG. 13 illustrates the reduced coaption angle ⁇ of the preferred embodiment.
  • FIG. 1 illustrates a preferred embodiment of the assembled autologous tissue heart valve 9 .
  • This valve uses the patient's own tissue and is constructed intraoperatively from several factory manufactured components.
  • these components include a tissue mounting frame 40 (FIG. 3C) having a plurality of tissue anchor hooks 34 and 36 .
  • This tissue mounting frame 40 mounts three individual autologous tissue leaflets 50 , one such leaflet being shown in FIG. 7A.
  • the final assembled configuration of the three leaflets is shown at 90 in FIG. 1.
  • An elastomeric outer sheath 42 covers the tissue mounting frame and assists in holding the tissue in place on the frame without placing undue stress on the tissue leaflets.
  • An annular sewing ring 70 is mounted at the base of the tissue mounting frame and elastomeric sheath and used in the conventional manner to hold the assembled valve 9 in place within the patient's heart. As described below, this valve is designed to be intraoperatively assembled by the surgeon during the open heart procedure. Typical assembly times are of the order of 10 minutes.
  • FIGS. 2A, 2B, 3 A, 3 B, 3 C, 3 D, 4 and 5 The components of tissue mounting frame 40 are shown in FIGS. 2A, 2B, 3 A, 3 B, 3 C, 3 D, 4 and 5 .
  • the inner frame 10 preferably manufactured with a base 12 having three commissure posts 14 extending from the base.
  • these commissure posts 14 are located along the axis of the valve in the direction of blood flow through the valve.
  • the three commissure posts 14 are spaced uniformly along the inner frame so that when the inner frame is assembled, the three commissure posts are separated by 120 degrees.
  • the posts are preferably connected with scalloped walls 16 and the ends 18 of the inner frame are preferably slanted at an angle rather than being perpendicular to the base 12 .
  • a plurality of inner frame holes 20 are located along the perimeter of the scalloped walls 16 and commissure posts 14 .
  • the inner frame 10 may be made of a variety of materials suitable for in vivo use, including certain metals and plastics. Metal is generally preferred over plastic as a material of construction and ELGILOY is an especially preferred metal for fabricating the inner frame 10 . DELRIN is an especially preferred plastic.
  • FIG. 2B shows the outer frame 24 portion of the tissue mounting frame 40 .
  • the outer frame just as the inner frame, is constructed with a base 12 a with a plurality of commissure posts 14 a connected by a scalloped walls 16 a .
  • the ends 18 a of the outer frame are also preferably slanted.
  • a plurality of outer frame holes 26 are located along a cusp line 30 , shown as a dashed line in FIG. 2B. This cusp line 30 is located close to the perimeter of the scalloped walls 16 and commissure posts 14 a .
  • the number of inner outer frame holes depend on the size of the valve but are generally in the range of 21 to 24 .
  • the outer frame holes are formed to be juxtaposed with the corresponding inner frame holes when the inner and outer frames are assembled together.
  • the outer frame can also be made of a variety of materials including certain metal and plastic. ELGILOY is especially preferred.
  • FIG. 2B The general location of a weld area 32 is shown on FIG. 2B with cross hatching. This weld area generally defines the area on the inner surface of the outer frame 24 which is later welded to the outer surface of the inner frame 10 to permanently bind the two frames together.
  • the inner frame 10 and outer frame 24 are rolled to form a cylindrical configuration.
  • the appearance of the two cylindrically shaped members are quite similar so that only the outer frame 24 is shown in FIG. 3A.
  • the two members 10 and 24 are then placed concentrically together and spot welded in the weld area 32 around the base 12 to form the structure shown in FIG. 3B.
  • the frame ends 18 and 18 a are placed 120 degrees apart when the two frames are welded together.
  • Commissure post anchors 34 (FIG. 4) and cusp line anchors 36 (FIG. 5) are fabricated from metal, preferably ELGILOY.
  • These anchors 34 , 36 each include hook portions and a tang portion ( 34 a and 36 a ), the latter being used to permanently attach the anchors to the tissue mounting frame 40 .
  • the hook portions are inserted from within the cylinder of the joined inner and outer frames through the inner frame holes 20 and outer frame holes 26 so that the hook portion extends outside of the surface of the outer frame (as shown in FIGS. 3C and 3B).
  • the tang portion 36 is spot welded to the inner surface of the outer frame 24 through the corresponding larger inner frame hole 20 located in the inner frame 10 . As best shown in FIG.
  • the tang portion 34 a abuts the inner surface of the outer frame 24 and resides within the corresponding larger inner frame hole 20 .
  • the commissure post anchors 34 are slightly longer than the cusp line anchors 36 , because they hold two layers of tissue rather than one layer for the cusp line anchors.
  • FIG. 3D shows a more detailed view of the commissure post anchors 34 which extend through the outer frame hole 26 in the outer frame 24 .
  • the tang portion of the commissure post anchor 34 is spot welded to the inner wall of the outer frame 24 through the larger inner frame hole 20 (not shown) of the inner frame 10 .
  • FIGS. 3C, 3D and 6 the hook portions on the commissure post anchors 34 point upwardly, while FIG. 3C shows that the hook portions of the cusp line anchors 36 point away and downwardly from the cusp line 30 .
  • the tissue mounting frame 40 is manufactured in several sizes to suit the particular needs of the patient after the surgeon has removed the patient's valve during open heart surgery. Typical sizes in current use include 19, 21, 23 and 25 mm valves.
  • the number of cusp line anchors vary, depending on the size of the tissue mounting frame. Normally, there are 6 commissure post anchors (2 per post) and 15-18 cusp line anchors per valve. The number of cusp line anchors depends on the size of the valve.
  • FIG. 6 shows a cross-sectional view of one side of the assembled tissue mounting frame 40 showing the inner frame 10 , outer frame 24 , and commissure post anchors 34 .
  • the two commissure post anchors 34 are welded to the inner wall of the outer frame 24 through the inner frame holes 20 .
  • the cusp line anchors 34 are similarly welded to the lower part of the frame 40 .
  • DACRON is the trademarked name registered to DuPont for polyethylene terephthalate.
  • FIGS. 10C, 11B, 11 C show DACRON cloth 38 as a broken line 38 over the mounting frame 40 as well as the sheath 42 and sewing ring 70 , described below.
  • the commissure post anchors 34 and cusp line anchors 36 extend through the DACRON.
  • the spot welded anchors are flush with and only slightly protrude (typically 0.003 inches) above the inner surface of the inner frame.
  • the inside surface is smooth, except for the knitted surface of the DACRON. Covering the frame with DACRON isolates the non-biological material, such as the metal of the frame, from the body.
  • the DACRON cover for the frame can be prepared in a variety of ways, one advantageous method was described in U.S. Pat. No. 5,163,955, herein incorporated by reference.
  • a three-fingered DACRON sock or glove is described and shown in FIG. 4A of the patent.
  • the three-fingered sock is formed by heat seaming sections of DACRON fabric together utilizing either hot wire, hot soldering iron, or ultrasonic techniques.
  • the entire glove can be woven or knitted as one piece. The glove is then turned inside out (to remove the seam from the bloodstream), pulled over the tissue frame and secured with a heat seam at the base of the glove. Similar fabrication methods can be used for the other DACRON coverings described herein.
  • the autologous tissue leaflets 50 have a roughly semicircular shape as shown in FIG. 7A. Details of these leaflets, including the manner in which they are formed, is provided below. These tissue leaflets 50 are formed with a plurality of tissue anchoring holes 58 located along a tissue cusp line 62 , shown as a dashed line on FIG. 7A. A tissue leaflet chamfer 66 is preferably cut in one corner to identify which leaflet is to be placed on top and overlap a portion of the preceding leaflet. During the intraoperative construction of the valve, these tissue holes 58 are fitted over the commissure post anchors 34 and cusp line anchors 36 to properly position the tissue leaflets to the assembled tissue frame.
  • tissue leaflets 50 The attachment of the tissue leaflets 50 to the commissure post anchors is shown in FIG. 8. As shown, overlapping tissue leaflets 50 a and 50 b are attached to the tissue mounting frame 40 by having the tissue anchoring holes 58 inserted over the hook portions commissure post anchors 34 . As a result, two layers of tissue leaflets 50 are attached to each of the commissure post anchors 34 . However, only one tissue leaflet is present in the lower part of the frame where the leaflets do not overlap.
  • the cusp line anchors 36 (not shown in its FIG. 8) have a hook portion that does not extend as far out from the frame 40 .
  • the elastomeric sheath 42 is shown in FIG. 9A.
  • This elastomeric sheath has a generally similar shape to that of the tissue mounting frame 40 , with an annular elastomeric sheath base 44 and three elastomeric sheath commissure posts 46 extending from the base.
  • the elastomeric sheath commissure posts 46 are connected with elastomeric sheath scalloped walls 48 .
  • a plurality of elastomeric sheath holes 64 correspond in position and number to those of the commissure post anchors 34 and the cusp line anchors 36 on the frame 40 .
  • the elastomeric sheath 42 is preferably made from silicone rubber covered on both sides with DACRON cloth.
  • FIGS. 9A, 10A, 10 B, 10 C, 11 A and 11 B Additional views of the elastomeric sheath 42 are shown in FIGS. 9A, 10A, 10 B, 10 C, 11 A and 11 B.
  • FIGS. 10A, 10B and 11 A are for illustrative purposes only since the sheath is shown in these figures attached to the frame 40 without the autologous leaflets 50 . Such would not occur during construction of the valve since these leaflets would be first attached to the tissue mounting frame 40 by the tissue anchors 34 , 36 and only afterwards is the sheath 42 moved into position.
  • the cross-section of the elastomeric sheath 42 shown best in FIG. 9B, is somewhat like an inverted “J” with two rims adjacent to the elastomeric sheath base 44 .
  • the elastomeric sheath 42 is designed to be stretch-fit over the assembled frame structure having the three leaflets 50 attached.
  • the tissue anchors 34 and 36 locate loosely within the DACRON covered elastomeric sheath holes 50 , as best shown in FIG. 11B.
  • the top of the inverted “J” of the outer elastomeric sheath fits over the top of the commissure posts 14 of the frame 40 .
  • the elastomeric sheath holes 64 accommodate the hook section of the commissure post anchors 34 and cusp line anchors 36 which protrude beyond the tissue.
  • FIG. 10A shows the commissure post anchors 34 fitted into the elastomeric sheath holes 64 .
  • the elastomeric sheath 42 is fixed by its DACRON cover to the base of the frame assembly by thermally welding, suturing, or sewing it to the DACRON cover of the frame assembly.
  • the elastomeric sheath 42 is also held in position on the commissure posts 14 of the frame by a elastomeric sheath pocket 84 situated at the top of the inverted “J” of the outer sheath (FIG. 11B).
  • a DACRON covered sewing ring 70 shown in FIGS. 11A, 11B, 11 C and 12 A, 12 B, is located at the base of the assembled valve.
  • the sewing ring advantageously has a wedge shaped cross-section and is preferably made of silicon rubber, though other materials can be used, provided that they are flexible, resilient, and durable.
  • the sewing ring is thin and flexible so that it can accurately conform to the scalloped shape of the aortic root when the valve is implanted into the patient.
  • the sewing ring, tissue mounting frame, and elastomeric sheath are joined together by joining all six layers of DACRON together in a thermal weld point 110 , shown in FIGS. 11B and 11C.
  • the thermal weld 110 is formed with the sewing ring almost in line with the tissue mounting frame.
  • the weld point is hidden between the sewing ring and the outer sheath. This prevents thromboembolisms from forming on the relatively smooth surface of the weld.
  • the tissue mounting frame, tissue anchors, and elastomeric sheath comprise a kit which can be preassembled in the factory and shipped for use in an operating room.
  • the kit can be fitted together and the elastomeric sheath aligned with the tissue mounting frame in the factory.
  • the tissue mounting frame, and elastomeric sheath are covered with DACRON, and the layers of DACRON are welded together with the thermal weld point 110 shown in FIGS. 11B and 11C, as previously described.
  • the kit can additionally comprise a sewing ring attached to the tissue mounting frame and elastomeric sheath.
  • the sewing ring is also covered with DACRON and is attached to the tissue mounting frame and elastomeric sheath by welding the six DACRON layers together in a thermal weld point 110 , as previously described.
  • each tissue leaflet 50 is shown in FIG. 7A.
  • the shape has been designed to form a cusp shape and to minimize tissue stress.
  • the length of tissue along the tissue cusp line 94 is slightly greater than the cusp line length 30 of the tissue frame, as shown in FIG. 2B, so that the extra tissue can form a cup shape, a process not dissimilar from that used to form the bust in ladies dresses.
  • there is more tissue than required for the cusp length it is not sufficient to cause folds or wrinkles in the tissue.
  • tissue leaflets are typically cut with a tissue cutting die configured to both the size of the ultimate valve and also to provide for additional tissue on one side of the leaflet.
  • tissue cutting dies suitable for cutting predetermined shapes in autologous tissue are shown and described in U.S. Pat. Nos. 5,163,955 and 5,425,741.
  • disposable tissue cutting dies will be supplied and used in a housing which may be non-disposable.
  • the cutting die is configured so that the tissue leaflets 50 are cut in a manner to take account of the extra tissue required for the overlap on the commissure posts 14 as shown in FIG. 11B.
  • the radius along the coaptation line of the leaflet whose tissue, at the commissure post, is on top of the adjacent leaflet (leaflet 50 a in FIG. 11B) is lengthened by the extra amount needed to overlay the inner leaflet.
  • the tissue cutting die or other cutting device is configured to provide for this extra tissue on one side of the leaflet and also chamfer one comer of the cut leaflet to identify which leaflet is placed on top of the preceding leaflet.
  • the tissue leaflet chamfer 66 is shown in FIG. 7A.
  • FIG. 10C The greater length of the side of the tissue leaflet which is on top is shown in FIG. 10C.
  • the radius along the coaptation line of the leaflet whose tissue is on top of the adjacent leaflet (leaflet 50 a in FIG. 11B) is lengthened by the extra amount needed to overlay the inner leaflet.
  • the extra tissue, as measured from the centerline of the tissue leaflet, is shown as the crosshatched area 98 in FIG. 7B.
  • tissue cutting die In addition to the tissue cutting die, other techniques can be employed to precisely cut the tissue leaflets, examples being water jet or laser cutting apparatus.
  • a feature of the preferred embodiment of the invention is that it does not require a horizontal coaptation line.
  • a horizontal coaptation line 104 significantly increases the stress in the tissue at the commissure post 14 .
  • This is analogous to the tension required to hold a washing line very taut compared to a line which is allowed to have a degree of curvature.
  • the outer elastomeric sheath 42 holds the tissue leaflets 50 a and 50 b around the commissure post 14 of the tissue mounting frame 40 .
  • the tissue length along the coaptation line is more than twice the radius of the valve. Taking account of tissue stretch, this extra tissue results in a coaptation to commissure post angle of approximately 65 degrees labelled as 102 in FIG. 13. This reduced coaptation angle ⁇ greatly reduces the stress in the tissue leaflets at the commissure post 14 .
  • the tissue for constructing the tissue leaflets 50 is preferably autogenous tissue, such as pericardial tissue, but it may also be fascia lata, rectus fascia, or vein tissue. These tissue sources are all relatively flimsy and difficult to handle. This is because, once harvested, the tissue will have a thickness of about 10-12 mils. By comparison, bovine pericardium is about 15-20 mils thick. After the tissue is harvested, it is usually partially fixed by immersion in 0.625% glutaraldehyde solution for approximately 10 minutes. This both toughens the tissue and makes it easier to handle.
  • tissue sources besides autogenous tissue are, of course, possible, such as bovine pericardium or other xenograft tissue or the like. Further, homograft tissue is possible. These tissues could be pre-cut by the valve builder or manufacturer outside the operating room and stored via conventional methods. If other tissue sources are used, however, the dimensions of the components would be adjusted to accommodate the tissue, which is generally thicker than the preferred tissue sources.
  • the three leaflets are placed on top of the preceding leaflets.
  • the leaflets are placed sequentially on the tissue anchor hooks 34 , 36 in the cloth covered tissue mounting frame 40 .
  • the elastomeric sheath 42 is then rolled-up over the frame 40 and the mounted tissue leaflets so that the concave pocket 84 situated at the top of each elastomeric sheath commissure post section 46 of the sheath 42 is hooked over to a commissure post 14 of the tissue mounting frame 40 .
  • the DACRON covered elastomeric sheath rests gently on the tissue leaflets around the cusp line (see FIG. 11C) such that the tissue leaflets form the naturally closed valve shown in FIG. 1.
  • Sheath 42 prevents the tissue leaflets 50 from coming off the tissue anchor hooks 34 , 36 , and the sheath substantially encloses and “hugs” the upper portion of the commissure posts 14 and the tissue leaflets attached thereto, as shown in FIG. 10C, so that the adjacent leaflets touch each other in the coaptation line.

Abstract

An apparatus and a method for constructing a heart valve prepared from autologous tissue is disclosed. Three tissue leaflets are held in place with tissue anchors on a tissue mounting frame having an annular base and a plurality of commissure posts extending from the base. An elastomeric sheath rests gently on the tissue leaflets to prevent the leaflets from coming off of the anchor hooks and encloses the leaflets to form valve cusps. The leaflets touch each other on a coaptation line with an angle of approximately 65° C. relative to the commissure post. The heart valves can be constructed intraoperatively in a short time, typically ten minutes. The low coaptation angle and the fact that the leaflets are held in place without being clamped between two unyielding members minimize stress on the tissue.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of Application Ser. No. 09/161,809, filed Sep. 28, 1998.[0001]
  • FIELD OF THE INVENTION
  • This invention relates to improvements in heart valves using autologous tissue held in place by anchors and an outer sheath. The heart valve can be constructed intraoperatively within a short time, typically 10 minutes. [0002]
  • BACKGROUND OF THE INVENTION
  • Several types of heart valves are presently available for use in replacing diseased or malfunctioning heart valves in humans. [0003]
  • One form of heart valve is constructed from animal tissue, typically from bovine or porcine aortic valve tissue. These valves must typically be constructed in a laboratory well in advance of when they will be needed and then stored in an aldehyde solution. Skilled technicians are required to assemble these valves. The valves constructed from animal tissue have relatively short lifetimes. The short lifetimes are caused by two factors. First, there is an antigenic reaction by the body to the animal tissue which causes the tissue to calcify, making it inflexible and more susceptible to failure with time. Second, the tissue is often stored in glutaraldehyde before implantation to try to decrease the antigenic reaction. The aldehyde tends to tan the tissue to a leather-like consistency, which makes it wear out from the repeated stress of opening and closing. [0004]
  • Thus, although these animal tissue valves are widely used, they have to be replaced after about five to ten years. Replacing the valves poses risks to the patient, because a second open heart operation is then needed, with the attendant possibility of problems during the operation. [0005]
  • Mechanical heart valves are also available. These valves are made from hard, non-biological materials such as metals or ceramics. Although the mechanical heart valves are durable, the hard, non-biological surfaces on the valves tend to cause blood clots. The blood clots can cause heart attacks or strokes, and, as a result, patients with mechanical heart valves must take anticoagulant drugs. These drugs can lead to hemorrhagic complications. Also, patients on these drugs require frequent and life-long laboratory tests of their clotting time. [0006]
  • Another type of heart valve, the autogenous tissue valve, is constructed with the patient's own tissue. A number of patents for autologous tissue heart valves and methods of making autologous tissue heart valves have issued to Autogenics, assignee of this application, including U.S. Pat. Nos. 5,161,955 and 5,326,371. [0007]
  • SUMMARY OF THE INVENTION
  • The preferred embodiments provide improved apparatus and methods for constructing an autologous heart valve. A significant factor is that both the configuration of the autologous tissue and its means for attachment to the frame of the valve prevent deleterious stress on the tissue. [0008]
  • Accurate placement of the autologous tissue is provided by forming pericardium tissue taken from the patient into three separate tissue leaflets, each generally semi-circular shape and having a plurality of tissue anchor holes located along a tissue cusp line. The location of these tissue anchor holes correspond to tissue anchor hooks permanently attached to a tissue mounting frame. [0009]
  • These three leaves of tissue are placed sequentially on the tissue anchor hooks of the tissue mounting frame so as to be located completely around the circumference of the tissue mounting frame. An elastomeric sheath is stretched over the exterior of the tissue mounting frame. This sheath prevents the tissue from coming off the tissue anchor hooks and rests gently on the tissue around the cusp line such that the tissue forms a naturally closed valve. [0010]
  • A significant feature is that the manner in which the autologous tissue is supported prevents deterioration stress on the tissue. The tissue is thus not clamped between two unyielding members, but rather supported and retained by the combination of anchors mated in tissue anchor holes and the elastomeric sheath engaging a peripheral portion of the tissue leaflets between the elastomeric sheath member and the inner tissue mounting frame. [0011]
  • Another feature is that the tissue leaflets are formed to include sufficient extra tissue area to provide a physiologically representative coaptation line angle to thereby reduce the stretch in the tissue held in place by the sheath and thus further reduce the stress in the tissue.[0012]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a preferred embodiment of an assembled autologous heart valve constructed in accordance with preferred methods; [0013]
  • FIG. 2A is a front view during manufacture of the inner frame portion of the tissue mounting frame; [0014]
  • FIG. 2B is a front view during manufacture of the outer frame portion of the tissue mounting frame; [0015]
  • FIG. 3A is a perspective view of the outer frame after it has been rolled into a cylindrical configuration; [0016]
  • FIG. 3B is a perspective view of the inner and outer frames concentrically joined together; [0017]
  • FIG. 3C is a perspective of the completed tissue mounting frame with tissue anchors before it is covered with cloth; [0018]
  • FIG. 3D is an enlarged perspective view showing one of the commissure post anchors; [0019]
  • FIG. 4 is an enlarged view of the commissure tissue anchors; [0020]
  • FIG. 5 is an enlarged view of the cusp tissue anchor ; [0021]
  • FIG. 6 is a cross-sectional view taken along line [0022] 6-6 of FIG. 3C;
  • FIG. 7A is a front view of one of the autologous tissue leaflets; [0023]
  • FIG. 7B is a front view of the autologous tissue leaflet of FIG. 7A, showing the excess tissue for overlap of the tissue leaflets on the commissure hooks; [0024]
  • FIG. 8 is the cross-sectional view of FIG. 6 with the addition of two overlapping autologous tissue leaflets; [0025]
  • FIG. 9A is a perspective view of the elastomeric sheath; [0026]
  • FIG. 9B is a cross-sectional view taken along [0027] line 9B-9B of FIG. 9A;
  • FIG. 10A is a perspective view of the elastomeric sheath attached to the tissue mounting frame; [0028]
  • FIG. 10B is a front view of the elastomeric sheath shown in FIG. 10A; [0029]
  • FIG. 10C is a sectional view taken along [0030] line 10C-10C of FIG. 1;
  • FIG. 11A is a sectional view taken along [0031] line 11A-11A of FIG. 1;
  • FIG. 11B is a cross-sectional view of [0032] line 11B-11B of FIG. 1;
  • FIG. 11C is a cross-sectional view of [0033] line 11C-11C of FIG. 1;
  • FIG. 12A is a perspective view of the annular sewing ring before it is covered with cloth; [0034]
  • FIG. 12B is a cross-sectional view taken along [0035] line 12B-12B of FIG. 12A; and
  • FIG. 13 illustrates the reduced coaption angle θ of the preferred embodiment.[0036]
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1 illustrates a preferred embodiment of the assembled autologous [0037] tissue heart valve 9. This valve uses the patient's own tissue and is constructed intraoperatively from several factory manufactured components. Referring to FIGS. 3C and 7A, these components include a tissue mounting frame 40 (FIG. 3C) having a plurality of tissue anchor hooks 34 and 36. This tissue mounting frame 40 mounts three individual autologous tissue leaflets 50, one such leaflet being shown in FIG. 7A. The final assembled configuration of the three leaflets is shown at 90 in FIG. 1. An elastomeric outer sheath 42 covers the tissue mounting frame and assists in holding the tissue in place on the frame without placing undue stress on the tissue leaflets. An annular sewing ring 70 is mounted at the base of the tissue mounting frame and elastomeric sheath and used in the conventional manner to hold the assembled valve 9 in place within the patient's heart. As described below, this valve is designed to be intraoperatively assembled by the surgeon during the open heart procedure. Typical assembly times are of the order of 10 minutes.
  • Tissue Mounting Frame 40
  • The components of [0038] tissue mounting frame 40 are shown in FIGS. 2A, 2B, 3A, 3B, 3C, 3D, 4 and 5. Shown in FIG. 2A is the inner frame 10 preferably manufactured with a base 12 having three commissure posts 14 extending from the base. In the constructed valve shown in FIG. 1, these commissure posts 14 are located along the axis of the valve in the direction of blood flow through the valve. Preferably, the three commissure posts 14 are spaced uniformly along the inner frame so that when the inner frame is assembled, the three commissure posts are separated by 120 degrees. The posts are preferably connected with scalloped walls 16 and the ends 18 of the inner frame are preferably slanted at an angle rather than being perpendicular to the base 12. A plurality of inner frame holes 20 are located along the perimeter of the scalloped walls 16 and commissure posts 14.
  • The [0039] inner frame 10 may be made of a variety of materials suitable for in vivo use, including certain metals and plastics. Metal is generally preferred over plastic as a material of construction and ELGILOY is an especially preferred metal for fabricating the inner frame 10. DELRIN is an especially preferred plastic.
  • FIG. 2B shows the [0040] outer frame 24 portion of the tissue mounting frame 40. The outer frame, just as the inner frame, is constructed with a base 12 a with a plurality of commissure posts 14 a connected by a scalloped walls 16 a. The ends 18 a of the outer frame are also preferably slanted. A plurality of outer frame holes 26 are located along a cusp line 30, shown as a dashed line in FIG. 2B. This cusp line 30 is located close to the perimeter of the scalloped walls 16 and commissure posts 14 a. The number of inner outer frame holes depend on the size of the valve but are generally in the range of 21 to 24. As described below, the outer frame holes are formed to be juxtaposed with the corresponding inner frame holes when the inner and outer frames are assembled together. The outer frame can also be made of a variety of materials including certain metal and plastic. ELGILOY is especially preferred.
  • The general location of a [0041] weld area 32 is shown on FIG. 2B with cross hatching. This weld area generally defines the area on the inner surface of the outer frame 24 which is later welded to the outer surface of the inner frame 10 to permanently bind the two frames together.
  • The [0042] inner frame 10 and outer frame 24 are rolled to form a cylindrical configuration. The appearance of the two cylindrically shaped members are quite similar so that only the outer frame 24 is shown in FIG. 3A. The two members 10 and 24 are then placed concentrically together and spot welded in the weld area 32 around the base 12 to form the structure shown in FIG. 3B. The frame ends 18 and 18 a are placed 120 degrees apart when the two frames are welded together.
  • Commissure post anchors [0043] 34 (FIG. 4) and cusp line anchors 36 (FIG. 5) are fabricated from metal, preferably ELGILOY. These anchors 34, 36 each include hook portions and a tang portion (34 a and 36 a), the latter being used to permanently attach the anchors to the tissue mounting frame 40. The hook portions are inserted from within the cylinder of the joined inner and outer frames through the inner frame holes 20 and outer frame holes 26 so that the hook portion extends outside of the surface of the outer frame (as shown in FIGS. 3C and 3B). The tang portion 36 is spot welded to the inner surface of the outer frame 24 through the corresponding larger inner frame hole 20 located in the inner frame 10. As best shown in FIG. 6, the tang portion 34 a abuts the inner surface of the outer frame 24 and resides within the corresponding larger inner frame hole 20. As shown in FIGS. 4 and 5, and as will become clear below, the commissure post anchors 34 are slightly longer than the cusp line anchors 36, because they hold two layers of tissue rather than one layer for the cusp line anchors.
  • FIG. 3D shows a more detailed view of the commissure post anchors [0044] 34 which extend through the outer frame hole 26 in the outer frame 24. The tang portion of the commissure post anchor 34 is spot welded to the inner wall of the outer frame 24 through the larger inner frame hole 20 (not shown) of the inner frame 10.
  • As shown in FIGS. 3C, 3D and [0045] 6, the hook portions on the commissure post anchors 34 point upwardly, while FIG. 3C shows that the hook portions of the cusp line anchors 36 point away and downwardly from the cusp line 30. Normally, but not necessarily, there are two commissure post anchors 34 on each commissure post 14.
  • The [0046] tissue mounting frame 40 is manufactured in several sizes to suit the particular needs of the patient after the surgeon has removed the patient's valve during open heart surgery. Typical sizes in current use include 19, 21, 23 and 25 mm valves. The number of cusp line anchors vary, depending on the size of the tissue mounting frame. Normally, there are 6 commissure post anchors (2 per post) and 15-18 cusp line anchors per valve. The number of cusp line anchors depends on the size of the valve.
  • FIG. 6 shows a cross-sectional view of one side of the assembled [0047] tissue mounting frame 40 showing the inner frame 10, outer frame 24, and commissure post anchors 34. The two commissure post anchors 34 are welded to the inner wall of the outer frame 24 through the inner frame holes 20. Although not shown, the cusp line anchors 34 are similarly welded to the lower part of the frame 40.
  • After the [0048] inner frame 10, outer frame 24, commissure post anchors 34, and cusp line anchors 36 have been assembled and welded together, the assembled tissue mounting frame 40 is covered on both sides with DACRON cloth 38 (see FIG. 11B). DACRON is the trademarked name registered to DuPont for polyethylene terephthalate.
  • Since it is difficult to illustrate the cloth in the drawings, certain of the cross-sectional views, FIGS. 10C, 11B, [0049] 11C, show DACRON cloth 38 as a broken line 38 over the mounting frame 40 as well as the sheath 42 and sewing ring 70, described below. The commissure post anchors 34 and cusp line anchors 36 extend through the DACRON. As noted above, the spot welded anchors are flush with and only slightly protrude (typically 0.003 inches) above the inner surface of the inner frame. As a result, when the frame is covered with DACRON, the inside surface is smooth, except for the knitted surface of the DACRON. Covering the frame with DACRON isolates the non-biological material, such as the metal of the frame, from the body. It also accomplishes the purpose of promoting tissue ingrowth into the interstices of the fabric, to further isolate the non-biological material from the body and integrate the valve into the heart. This helps avoid the problem of thromboembolism. Additionally, it provides a gentle interface between the metal and plastic components of the valve and the tissue and helps to nurture the tissue and promote its viability by allowing free passage of blood to the tissue.
  • Although the DACRON cover for the frame can be prepared in a variety of ways, one advantageous method was described in U.S. Pat. No. 5,163,955, herein incorporated by reference. A three-fingered DACRON sock or glove is described and shown in FIG. 4A of the patent. The three-fingered sock is formed by heat seaming sections of DACRON fabric together utilizing either hot wire, hot soldering iron, or ultrasonic techniques. Alternatively, the entire glove can be woven or knitted as one piece. The glove is then turned inside out (to remove the seam from the bloodstream), pulled over the tissue frame and secured with a heat seam at the base of the glove. Similar fabrication methods can be used for the other DACRON coverings described herein. [0050]
  • Autologous Tissue Leaflets
  • The [0051] autologous tissue leaflets 50 have a roughly semicircular shape as shown in FIG. 7A. Details of these leaflets, including the manner in which they are formed, is provided below. These tissue leaflets 50 are formed with a plurality of tissue anchoring holes 58 located along a tissue cusp line 62, shown as a dashed line on FIG. 7A. A tissue leaflet chamfer 66 is preferably cut in one corner to identify which leaflet is to be placed on top and overlap a portion of the preceding leaflet. During the intraoperative construction of the valve, these tissue holes 58 are fitted over the commissure post anchors 34 and cusp line anchors 36 to properly position the tissue leaflets to the assembled tissue frame. The attachment of the tissue leaflets 50 to the commissure post anchors is shown in FIG. 8. As shown, overlapping tissue leaflets 50 a and 50 b are attached to the tissue mounting frame 40 by having the tissue anchoring holes 58 inserted over the hook portions commissure post anchors 34. As a result, two layers of tissue leaflets 50 are attached to each of the commissure post anchors 34. However, only one tissue leaflet is present in the lower part of the frame where the leaflets do not overlap. The cusp line anchors 36 (not shown in its FIG. 8) have a hook portion that does not extend as far out from the frame 40.
  • Elastomeric Sheath
  • The [0052] elastomeric sheath 42 is shown in FIG. 9A. This elastomeric sheath has a generally similar shape to that of the tissue mounting frame 40, with an annular elastomeric sheath base 44 and three elastomeric sheath commissure posts 46 extending from the base. The elastomeric sheath commissure posts 46 are connected with elastomeric sheath scalloped walls 48. A plurality of elastomeric sheath holes 64 correspond in position and number to those of the commissure post anchors 34 and the cusp line anchors 36 on the frame 40. The elastomeric sheath 42 is preferably made from silicone rubber covered on both sides with DACRON cloth.
  • Additional views of the [0053] elastomeric sheath 42 are shown in FIGS. 9A, 10A, 10B, 10C, 11A and 11B. Please note that the FIGS. 10A, 10B and 11A are for illustrative purposes only since the sheath is shown in these figures attached to the frame 40 without the autologous leaflets 50. Such would not occur during construction of the valve since these leaflets would be first attached to the tissue mounting frame 40 by the tissue anchors 34, 36 and only afterwards is the sheath 42 moved into position. The cross-section of the elastomeric sheath 42, shown best in FIG. 9B, is somewhat like an inverted “J” with two rims adjacent to the elastomeric sheath base 44. The elastomeric sheath 42 is designed to be stretch-fit over the assembled frame structure having the three leaflets 50 attached. When the elastomeric sheath 42 is stretched over the assembled frame structure, the tissue anchors 34 and 36 locate loosely within the DACRON covered elastomeric sheath holes 50, as best shown in FIG. 11B.
  • The top of the inverted “J” of the outer elastomeric sheath fits over the top of the commissure posts [0054] 14 of the frame 40. The tissue leaflets 50 attached to the commissure post anchors 34 and the cusp line hooks 36 and are then held in place between the inner wall of the elastomeric sheath 42 and the tissue mounting frame 40. The elastomeric sheath holes 64 accommodate the hook section of the commissure post anchors 34 and cusp line anchors 36 which protrude beyond the tissue. FIG. 10A shows the commissure post anchors 34 fitted into the elastomeric sheath holes 64.
  • The [0055] elastomeric sheath 42 is fixed by its DACRON cover to the base of the frame assembly by thermally welding, suturing, or sewing it to the DACRON cover of the frame assembly. The elastomeric sheath 42 is also held in position on the commissure posts 14 of the frame by a elastomeric sheath pocket 84 situated at the top of the inverted “J” of the outer sheath (FIG. 11B).
  • Sewing Ring
  • A DACRON covered [0056] sewing ring 70, shown in FIGS. 11A, 11B, 11C and 12A, 12B, is located at the base of the assembled valve. The sewing ring advantageously has a wedge shaped cross-section and is preferably made of silicon rubber, though other materials can be used, provided that they are flexible, resilient, and durable. The sewing ring is thin and flexible so that it can accurately conform to the scalloped shape of the aortic root when the valve is implanted into the patient.
  • The sewing ring, tissue mounting frame, and elastomeric sheath are joined together by joining all six layers of DACRON together in a [0057] thermal weld point 110, shown in FIGS. 11B and 11C. The thermal weld 110 is formed with the sewing ring almost in line with the tissue mounting frame. When the sewing ring is moved into the position shown in FIG. 11B, the weld point is hidden between the sewing ring and the outer sheath. This prevents thromboembolisms from forming on the relatively smooth surface of the weld.
  • The tissue mounting frame, tissue anchors, and elastomeric sheath comprise a kit which can be preassembled in the factory and shipped for use in an operating room. The kit can be fitted together and the elastomeric sheath aligned with the tissue mounting frame in the factory. Preferably, the tissue mounting frame, and elastomeric sheath are covered with DACRON, and the layers of DACRON are welded together with the [0058] thermal weld point 110 shown in FIGS. 11B and 11C, as previously described.
  • Optionally, the kit can additionally comprise a sewing ring attached to the tissue mounting frame and elastomeric sheath. Preferably, the sewing ring is also covered with DACRON and is attached to the tissue mounting frame and elastomeric sheath by welding the six DACRON layers together in a [0059] thermal weld point 110, as previously described.
  • Preparation of the Autologous Tissue Leaflets 50
  • The general shape of each [0060] tissue leaflet 50 is shown in FIG. 7A. The shape has been designed to form a cusp shape and to minimize tissue stress. The length of tissue along the tissue cusp line 94 is slightly greater than the cusp line length 30 of the tissue frame, as shown in FIG. 2B, so that the extra tissue can form a cup shape, a process not dissimilar from that used to form the bust in ladies dresses. Although there is more tissue than required for the cusp length, it is not sufficient to cause folds or wrinkles in the tissue.
  • The tissue leaflets are typically cut with a tissue cutting die configured to both the size of the ultimate valve and also to provide for additional tissue on one side of the leaflet. Examples of cutting dies suitable for cutting predetermined shapes in autologous tissue are shown and described in U.S. Pat. Nos. 5,163,955 and 5,425,741. In the preferred embodiment, disposable tissue cutting dies will be supplied and used in a housing which may be non-disposable. [0061]
  • For use in the preferred embodiments, the cutting die is configured so that the [0062] tissue leaflets 50 are cut in a manner to take account of the extra tissue required for the overlap on the commissure posts 14 as shown in FIG. 11B. The radius along the coaptation line of the leaflet whose tissue, at the commissure post, is on top of the adjacent leaflet (leaflet 50 a in FIG. 11B) is lengthened by the extra amount needed to overlay the inner leaflet. The tissue cutting die or other cutting device is configured to provide for this extra tissue on one side of the leaflet and also chamfer one comer of the cut leaflet to identify which leaflet is placed on top of the preceding leaflet. The tissue leaflet chamfer 66 is shown in FIG. 7A.
  • The greater length of the side of the tissue leaflet which is on top is shown in FIG. 10C. The radius along the coaptation line of the leaflet whose tissue is on top of the adjacent leaflet (leaflet [0063] 50 a in FIG. 11B) is lengthened by the extra amount needed to overlay the inner leaflet. The extra tissue, as measured from the centerline of the tissue leaflet, is shown as the crosshatched area 98 in FIG. 7B.
  • In addition to the tissue cutting die, other techniques can be employed to precisely cut the tissue leaflets, examples being water jet or laser cutting apparatus. [0064]
  • A feature of the preferred embodiment of the invention is that it does not require a horizontal coaptation line. As shown in FIG. 13, such a [0065] horizontal coaptation line 104 significantly increases the stress in the tissue at the commissure post 14. This is analogous to the tension required to hold a washing line very taut compared to a line which is allowed to have a degree of curvature. In the heart valves constructed according to preferred embodiments, the outer elastomeric sheath 42 holds the tissue leaflets 50 a and 50 b around the commissure post 14 of the tissue mounting frame 40. The tissue length along the coaptation line is more than twice the radius of the valve. Taking account of tissue stretch, this extra tissue results in a coaptation to commissure post angle of approximately 65 degrees labelled as 102 in FIG. 13. This reduced coaptation angle θ greatly reduces the stress in the tissue leaflets at the commissure post 14.
  • The tissue for constructing the [0066] tissue leaflets 50 is preferably autogenous tissue, such as pericardial tissue, but it may also be fascia lata, rectus fascia, or vein tissue. These tissue sources are all relatively flimsy and difficult to handle. This is because, once harvested, the tissue will have a thickness of about 10-12 mils. By comparison, bovine pericardium is about 15-20 mils thick. After the tissue is harvested, it is usually partially fixed by immersion in 0.625% glutaraldehyde solution for approximately 10 minutes. This both toughens the tissue and makes it easier to handle.
  • Other tissue sources besides autogenous tissue are, of course, possible, such as bovine pericardium or other xenograft tissue or the like. Further, homograft tissue is possible. These tissues could be pre-cut by the valve builder or manufacturer outside the operating room and stored via conventional methods. If other tissue sources are used, however, the dimensions of the components would be adjusted to accommodate the tissue, which is generally thicker than the preferred tissue sources. [0067]
  • Intraoperative Valve Construction
  • The cleaning, harvesting, and fixing processes for the autologous tissue are known in the art and described, for example, in U.S. Pat. No. 5,163,955. [0068]
  • Following fixing, the three [0069] separate leaflets 50 are cut, as described above.
  • The three leaflets, the dimensions of which allow for overlap with the cropped comer [0070] 66 (FIG. 7A) are placed on top of the preceding leaflets. The leaflets are placed sequentially on the tissue anchor hooks 34, 36 in the cloth covered tissue mounting frame 40.
  • The [0071] elastomeric sheath 42 is then rolled-up over the frame 40 and the mounted tissue leaflets so that the concave pocket 84 situated at the top of each elastomeric sheath commissure post section 46 of the sheath 42 is hooked over to a commissure post 14 of the tissue mounting frame 40. In the preferred embodiment, the DACRON covered elastomeric sheath rests gently on the tissue leaflets around the cusp line (see FIG. 11C) such that the tissue leaflets form the naturally closed valve shown in FIG. 1. Sheath 42 prevents the tissue leaflets 50 from coming off the tissue anchor hooks 34, 36, and the sheath substantially encloses and “hugs” the upper portion of the commissure posts 14 and the tissue leaflets attached thereto, as shown in FIG. 10C, so that the adjacent leaflets touch each other in the coaptation line.
  • The completed valve is tested and then mounted to a holder for implantation in accordance with the teachings of the prior art. See, e.g., U.S. Pat. No. 5,163,955. [0072]

Claims (11)

What is claimed is:
1. A heart valve comprising:
a frame comprising an annular base and a plurality of posts extending from said base;
a plurality of tissue anchors attached to said frame;
a plurality of tissue leaflets retained by said tissue anchors; and
a flexible elastomeric sheath, wherein said sheath fits around said frame and said tissue leaflets and retains said tissue leaflets on said tissue anchors.
2. The heart valve of claim 1, wherein said elastomeric sheath self adjusts to apply substantially equal force to said tissue leaflets on said frame.
3. The heart valve of claim 1, wherein the tissue leaflets are supported and retained by the combination of (i) said tissue anchors and (ii) said elastomeric sheath engaging a peripheral portion of said tissue leaflets between said elastomeric sheath and said frame, without clamping said tissue between two unyielding members.
4. The heart valve of claim 1, comprising 3 tissue leaflets retained by said tissue anchors.
5. The heart valve of claim 1, wherein said tissue leaflets comprise partially fixed autologous tissue.
6. The heart valve of claim 1, wherein said tissue leaflets comprise partially fixed autologous pericardial tissue.
7. The heart valve of claim 1, wherein said frame is covered with a fabric.
8. The heart valve of claim 1, wherein said elastomeric sheath is covered with a fabric.
9. The heart valve of claim 1, additionally comprising a flexible annular sewing ring.
10. The heart valve of claim 9, wherein said elastomeric sheath and said annular sewing ring are attached to said frame.
11. The heart valve of claim 1, wherein said tissue leaflets are assembled to said frame intraoperatively during a valve replacement operation.
US09/982,609 1998-09-28 2001-10-16 Heart valve having tissue alignment with anchors and an outer sheath Abandoned US20020026238A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/982,609 US20020026238A1 (en) 1998-09-28 2001-10-16 Heart valve having tissue alignment with anchors and an outer sheath

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/161,809 US6334873B1 (en) 1998-09-28 1998-09-28 Heart valve having tissue retention with anchors and an outer sheath
US09/982,609 US20020026238A1 (en) 1998-09-28 2001-10-16 Heart valve having tissue alignment with anchors and an outer sheath

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/161,809 Continuation US6334873B1 (en) 1998-09-28 1998-09-28 Heart valve having tissue retention with anchors and an outer sheath

Publications (1)

Publication Number Publication Date
US20020026238A1 true US20020026238A1 (en) 2002-02-28

Family

ID=22582838

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/161,809 Expired - Lifetime US6334873B1 (en) 1998-09-28 1998-09-28 Heart valve having tissue retention with anchors and an outer sheath
US09/982,609 Abandoned US20020026238A1 (en) 1998-09-28 2001-10-16 Heart valve having tissue alignment with anchors and an outer sheath

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/161,809 Expired - Lifetime US6334873B1 (en) 1998-09-28 1998-09-28 Heart valve having tissue retention with anchors and an outer sheath

Country Status (6)

Country Link
US (2) US6334873B1 (en)
EP (1) EP1117354A1 (en)
JP (1) JP2002525169A (en)
CN (1) CN1328436A (en)
AU (1) AU6259499A (en)
WO (1) WO2000018333A1 (en)

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122516A1 (en) * 2002-12-20 2004-06-24 Fogarty Thomas J. Biologically implantable prosthesis and methods of using the same
US20040127979A1 (en) * 2002-08-28 2004-07-01 Heart Leaflet Technologies, Inc Method of treating diseased valve
US20040138741A1 (en) * 2000-07-27 2004-07-15 Robert Stobie Heart valve holders and handling clips therefor
US6767362B2 (en) 2000-04-06 2004-07-27 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US20040210305A1 (en) * 2002-07-16 2004-10-21 Medtronic, Inc. Suture locking assembly and method of use
US20050043760A1 (en) * 2003-08-22 2005-02-24 Fogarty Thomas J. Prosthesis fixturing device and methods of using the same
US20050228494A1 (en) * 2004-03-29 2005-10-13 Salvador Marquez Controlled separation heart valve frame
US20060287717A1 (en) * 2005-05-24 2006-12-21 Rowe Stanton J Methods for rapid deployment of prosthetic heart valves
US20060293745A1 (en) * 2004-01-23 2006-12-28 Carpentier Alain F Anatomically approximate prosthetic mitral heart valve
US20070016285A1 (en) * 2005-05-27 2007-01-18 Ernest Lane Gasket with Collar for Prosthetic Heart Valves and Methods for Using Them
US20070225801A1 (en) * 2006-03-10 2007-09-27 Drews Michael J Valve introducers and methods for making and using them
US20070233228A1 (en) * 2006-03-28 2007-10-04 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US20070254273A1 (en) * 2006-05-01 2007-11-01 Hugues Lafrance Simulated heart valve root for training and testing
US20070265701A1 (en) * 2006-04-29 2007-11-15 Gurskis Donnell W Multiple component prosthetic heart valve assemblies and apparatus for delivering them
US20090192599A1 (en) * 2005-04-08 2009-07-30 Arbor Surgical Technologies, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US20090209982A1 (en) * 2005-11-25 2009-08-20 Universitat Zurich Biodegradable Scaffold
US20100010616A1 (en) * 2003-10-08 2010-01-14 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
US20100063363A1 (en) * 2005-02-10 2010-03-11 Hamman Baron L System, device, and method for providing access in a cardiovascular environment
US20100249908A1 (en) * 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
US20110098602A1 (en) * 2009-10-27 2011-04-28 Edwards Lifesciences Corporation Apparatus and Method for Measuring Body Orifice
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US8506625B2 (en) 2005-07-13 2013-08-13 Edwards Lifesciences Corporation Contoured sewing ring for a prosthetic mitral heart valve
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
US8986374B2 (en) 2010-05-10 2015-03-24 Edwards Lifesciences Corporation Prosthetic heart valve
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US9314334B2 (en) 2008-11-25 2016-04-19 Edwards Lifesciences Corporation Conformal expansion of prosthetic devices to anatomical shapes
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US9439762B2 (en) 2000-06-01 2016-09-13 Edwards Lifesciences Corporation Methods of implant of a heart valve with a convertible sewing ring
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US9504566B2 (en) 2014-06-20 2016-11-29 Edwards Lifesciences Corporation Surgical heart valves identifiable post-implant
US9549816B2 (en) 2014-04-03 2017-01-24 Edwards Lifesciences Corporation Method for manufacturing high durability heart valve
US9554901B2 (en) 2010-05-12 2017-01-31 Edwards Lifesciences Corporation Low gradient prosthetic heart valve
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
US10058425B2 (en) 2013-03-15 2018-08-28 Edwards Lifesciences Corporation Methods of assembling a valved aortic conduit
US10080653B2 (en) 2015-09-10 2018-09-25 Edwards Lifesciences Corporation Limited expansion heart valve
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
US10441415B2 (en) 2013-09-20 2019-10-15 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US10456246B2 (en) 2015-07-02 2019-10-29 Edwards Lifesciences Corporation Integrated hybrid heart valves
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
US10463485B2 (en) 2017-04-06 2019-11-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
US10543080B2 (en) 2011-05-20 2020-01-28 Edwards Lifesciences Corporation Methods of making encapsulated heart valves
US10667904B2 (en) 2016-03-08 2020-06-02 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
US10695170B2 (en) 2015-07-02 2020-06-30 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US10722316B2 (en) 2013-11-06 2020-07-28 Edwards Lifesciences Corporation Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage
US10799353B2 (en) 2017-04-28 2020-10-13 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
US11007058B2 (en) 2013-03-15 2021-05-18 Edwards Lifesciences Corporation Valved aortic conduits
US11135057B2 (en) 2017-06-21 2021-10-05 Edwards Lifesciences Corporation Dual-wireform limited expansion heart valves
US11337805B2 (en) 2018-01-23 2022-05-24 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
US11554012B2 (en) 2019-12-16 2023-01-17 Edwards Lifesciences Corporation Valve holder assembly with suture looping protection
US11690709B2 (en) 2015-09-02 2023-07-04 Edwards Lifesciences Corporation Methods for securing a transcatheter valve to a bioprosthetic cardiac structure

Families Citing this family (236)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US6736845B2 (en) * 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
JP2002541974A (en) * 1999-04-28 2002-12-10 セント・ジュード・メディカル・インコーポレーテッド Heart substitute valve
US6626899B2 (en) * 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US6991643B2 (en) 2000-12-20 2006-01-31 Usgi Medical Inc. Multi-barbed device for retaining tissue in apposition and methods of use
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US7195641B2 (en) * 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6709457B1 (en) * 1999-11-24 2004-03-23 St. Jude Medical, Inc. Attachment of suture cuff to prosthetic heart valve
US6872226B2 (en) * 2001-01-29 2005-03-29 3F Therapeutics, Inc. Method of cutting material for use in implantable medical device
DE10010074B4 (en) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for fastening and anchoring heart valve prostheses
DE10010073B4 (en) * 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring for implantable heart valve prostheses
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
FR2828263B1 (en) 2001-08-03 2007-05-11 Philipp Bonhoeffer DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE
US7097659B2 (en) * 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US6752828B2 (en) * 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7331993B2 (en) * 2002-05-03 2008-02-19 The General Hospital Corporation Involuted endovascular valve and method of construction
US8348963B2 (en) * 2002-07-03 2013-01-08 Hlt, Inc. Leaflet reinforcement for regurgitant valves
FR2846639B1 (en) * 2002-11-06 2004-12-10 Innovation Packaging PACKAGING AND DISPENSING DEVICE FOR A LIQUID OR SEMI-LIQUID PRODUCT
JP2006505363A (en) 2002-11-07 2006-02-16 アクシオム メディカル インク. Epicardial heart wire, thorax tube integrated with epicardial heart wire, and method of use thereof
US20050075725A1 (en) 2003-10-02 2005-04-07 Rowe Stanton J. Implantable prosthetic valve with non-laminar flow
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7976539B2 (en) 2004-03-05 2011-07-12 Hansen Medical, Inc. System and method for denaturing and fixing collagenous tissue
US8216299B2 (en) * 2004-04-01 2012-07-10 Cook Medical Technologies Llc Method to retract a body vessel wall with remodelable material
US7637937B2 (en) * 2004-04-08 2009-12-29 Cook Incorporated Implantable medical device with optimized shape
US20090030435A1 (en) * 2004-09-27 2009-01-29 Theranova, Llc Method and apparatus for anchoring cardiovascular implants
US7850704B2 (en) * 2004-09-27 2010-12-14 Theranova, Llc Method and apparatus for anchoring implants
US7989157B2 (en) * 2005-01-11 2011-08-02 Medtronic, Inc. Solution for storing bioprosthetic tissue used in a biological prosthesis
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US7722666B2 (en) * 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7238200B2 (en) * 2005-06-03 2007-07-03 Arbor Surgical Technologies, Inc. Apparatus and methods for making leaflets and valve prostheses including such leaflets
US7780723B2 (en) 2005-06-13 2010-08-24 Edwards Lifesciences Corporation Heart valve delivery system
US7632308B2 (en) * 2005-11-23 2009-12-15 Didier Loulmet Methods, devices, and kits for treating mitral valve prolapse
US20070168022A1 (en) * 2006-01-17 2007-07-19 Eldridge Charles J Heart valve
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
WO2008016578A2 (en) 2006-07-31 2008-02-07 Cartledge Richard G Sealable endovascular implants and methods for their use
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US8918193B2 (en) * 2006-08-16 2014-12-23 Vahe S. Yacoubian Heart wire
EP2077718B2 (en) 2006-10-27 2022-03-09 Edwards Lifesciences Corporation Biological tissue for surgical implantation
US8236045B2 (en) 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8409274B2 (en) 2007-04-26 2013-04-02 St. Jude Medical, Inc. Techniques for attaching flexible leaflets of prosthetic heart valves to supporting structures
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2009023818A1 (en) * 2007-08-15 2009-02-19 Theranova, Llc Method and apparatus for automated active sterilization of fully implanted devices
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
BRPI0817708A2 (en) 2007-09-26 2017-05-16 St Jude Medical prosthetic heart valve, and lamella structure for the same.
US8454686B2 (en) * 2007-09-28 2013-06-04 St. Jude Medical, Inc. Two-stage collapsible/expandable prosthetic heart valves and anchoring systems
US9532868B2 (en) 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US7981151B2 (en) * 2007-10-15 2011-07-19 Edwards Lifesciences Corporation Transcatheter heart valve with micro-anchors
US7846199B2 (en) * 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
EP4079261A1 (en) 2007-12-14 2022-10-26 Edwards Lifesciences Corporation Leaflet attachment frame for a prosthetic valve
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
CA2961051C (en) 2008-02-29 2020-01-14 Edwards Lifesciences Corporation Expandable member for deploying a prosthetic device
US9241792B2 (en) 2008-02-29 2016-01-26 Edwards Lifesciences Corporation Two-step heart valve implantation
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
DK3263070T3 (en) 2008-06-06 2020-01-20 Edwards Lifesciences Corp Low profile transcatheter heart valve
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
DE202009018961U1 (en) 2008-07-15 2014-11-26 St. Jude Medical, Inc. Heart valve prosthesis and arrangement for delivering a heart valve prosthesis
US9603558B2 (en) 2008-08-15 2017-03-28 Theranova, Llc Methods and devices for the diagnosis and treatment of diabetes
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US8690936B2 (en) 2008-10-10 2014-04-08 Edwards Lifesciences Corporation Expandable sheath for introducing an endovascular delivery device into a body
US20110011917A1 (en) * 2008-12-31 2011-01-20 Hansen Medical, Inc. Methods, devices, and kits for treating valve prolapse
AU2010226495A1 (en) * 2009-03-19 2011-09-29 Millipede Llc Reconfiguring heart features
GR1007028B (en) * 2009-11-11 2010-10-22 Ευσταθιος-Ανδρεας Αγαθος SUPPORT OF BIO-ADDITIONAL VALVES WITH DIAGNOSTIC HEART SHAPE
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
AU2010328106A1 (en) 2009-12-08 2012-07-05 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
US8795354B2 (en) 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
US20110224785A1 (en) 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
EP2656863B1 (en) 2010-03-23 2019-09-18 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
CN103153384B (en) 2010-06-28 2016-03-09 科利柏心脏瓣膜有限责任公司 For the device of device in the delivery of vascular of chamber
DK2590595T3 (en) 2010-07-09 2015-12-07 Highlife Sas Transcatheter atrioventricular heart valve prosthesis
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
EP4098227A1 (en) 2010-07-23 2022-12-07 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US20120053680A1 (en) 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
US8568475B2 (en) 2010-10-05 2013-10-29 Edwards Lifesciences Corporation Spiraled commissure attachment for prosthetic valve
ES2891075T3 (en) 2010-10-05 2022-01-26 Edwards Lifesciences Corp prosthetic heart valve
WO2012082952A2 (en) 2010-12-14 2012-06-21 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
GB2488530A (en) * 2011-02-18 2012-09-05 David J Wheatley Heart valve
US9155619B2 (en) 2011-02-25 2015-10-13 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
US9289282B2 (en) 2011-05-31 2016-03-22 Edwards Lifesciences Corporation System and method for treating valve insufficiency or vessel dilatation
US9358107B2 (en) * 2011-06-30 2016-06-07 Edwards Lifesciences Corporation Systems, dies, and methods for processing pericardial tissue
US8795357B2 (en) 2011-07-15 2014-08-05 Edwards Lifesciences Corporation Perivalvular sealing for transcatheter heart valve
JP2014524814A (en) 2011-07-20 2014-09-25 ボストン サイエンティフィック サイムド,インコーポレイテッド Heart valve replacement
US9339384B2 (en) 2011-07-27 2016-05-17 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
WO2013021374A2 (en) 2011-08-05 2013-02-14 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US20140324164A1 (en) 2011-08-05 2014-10-30 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
EP2739214B1 (en) 2011-08-05 2018-10-10 Cardiovalve Ltd Percutaneous mitral valve replacement and sealing
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
CA3040390C (en) 2011-08-11 2022-03-15 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
CA2852369A1 (en) 2011-10-21 2013-04-25 Jenavalve Technology Inc. Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
CA3097364C (en) 2011-12-09 2023-08-01 Edwards Lifesciences Corporation Prosthetic heart valve having improved commissure supports
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
EP3424469A1 (en) 2012-02-22 2019-01-09 Syntheon TAVR, LLC Actively controllable stent, stent graft and heart valve
DE202013011734U1 (en) 2012-05-16 2014-04-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. A catheter delivery system for inserting an expandable heart valve prosthesis and a medical device for treating a valvular defect
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US20140067048A1 (en) 2012-09-06 2014-03-06 Edwards Lifesciences Corporation Heart Valve Sealing Devices
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US9750595B2 (en) 2012-09-28 2017-09-05 Covidien Lp Implantable medical devices which include grip-members and methods of use thereof
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
ES2931210T3 (en) 2012-11-21 2022-12-27 Edwards Lifesciences Corp Retention Mechanisms for Prosthetic Heart Valves
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US9737398B2 (en) 2012-12-19 2017-08-22 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
US10039638B2 (en) 2012-12-19 2018-08-07 W. L. Gore & Associates, Inc. Geometric prosthetic heart valves
US10966820B2 (en) 2012-12-19 2021-04-06 W. L. Gore & Associates, Inc. Geometric control of bending character in prosthetic heart valve leaflets
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9681952B2 (en) 2013-01-24 2017-06-20 Mitraltech Ltd. Anchoring of prosthetic valve supports
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US9168129B2 (en) 2013-02-12 2015-10-27 Edwards Lifesciences Corporation Artificial heart valve with scalloped frame design
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
CA2908342C (en) 2013-05-20 2021-11-30 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
CA2914856C (en) 2013-06-25 2021-03-09 Chad Perrin Thrombus management and structural compliance features for prosthetic heart valves
CN105555231B (en) 2013-08-01 2018-02-09 坦迪尼控股股份有限公司 External membrane of heart anchor and method
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
WO2015058039A1 (en) 2013-10-17 2015-04-23 Robert Vidlund Apparatus and methods for alignment and deployment of intracardiac devices
CA2924389C (en) 2013-10-28 2021-11-09 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US9913715B2 (en) 2013-11-06 2018-03-13 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak sealing mechanism
CN111419472B (en) 2013-11-11 2023-01-10 爱德华兹生命科学卡迪尔克有限责任公司 System and method for manufacturing stent frames
US9622863B2 (en) 2013-11-22 2017-04-18 Edwards Lifesciences Corporation Aortic insufficiency repair device and method
US10098734B2 (en) 2013-12-05 2018-10-16 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US9504565B2 (en) 2013-12-06 2016-11-29 W. L. Gore & Associates, Inc. Asymmetric opening and closing prosthetic valve leaflet
WO2015120122A2 (en) 2014-02-05 2015-08-13 Robert Vidlund Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
CA2937566C (en) 2014-03-10 2023-09-05 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
EA034896B1 (en) 2014-05-09 2020-04-03 Фолдэкс, Инк. Replacement heart valve
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
US10195026B2 (en) 2014-07-22 2019-02-05 Edwards Lifesciences Corporation Mitral valve anchoring
WO2016016899A1 (en) 2014-07-30 2016-02-04 Mitraltech Ltd. Articulatable prosthetic valve
AU2015305868B2 (en) 2014-08-18 2018-09-20 Edwards Lifesciences Corporation Frame with integral sewing cuff for prosthetic valves
US10058424B2 (en) 2014-08-21 2018-08-28 Edwards Lifesciences Corporation Dual-flange prosthetic valve frame
US10016272B2 (en) 2014-09-12 2018-07-10 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
US9855141B2 (en) 2014-12-18 2018-01-02 W. L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
CR20170313A (en) * 2014-12-18 2017-08-29 Gore & Ass PROSTHETIC VALVES WITH MECHANICALLY COUPLED VALVES
JP6826035B2 (en) 2015-01-07 2021-02-03 テンダイン ホールディングス,インコーポレイテッド Artificial mitral valve, and devices and methods for its delivery
WO2016125160A1 (en) 2015-02-05 2016-08-11 Mitraltech Ltd. Prosthetic valve with axially-sliding frames
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
JP6718459B2 (en) 2015-02-05 2020-07-08 テンダイン ホールディングス,インコーポレイテッド Expandable epicardial pad and device and methods of delivery thereof
EP3256077A4 (en) 2015-02-13 2019-02-27 Millipede, Inc. Valve replacement using rotational anchors
US10327896B2 (en) 2015-04-10 2019-06-25 Edwards Lifesciences Corporation Expandable sheath with elastomeric cross sectional portions
US10792471B2 (en) 2015-04-10 2020-10-06 Edwards Lifesciences Corporation Expandable sheath
US10010417B2 (en) 2015-04-16 2018-07-03 Edwards Lifesciences Corporation Low-profile prosthetic heart valve for replacing a mitral valve
US10064718B2 (en) 2015-04-16 2018-09-04 Edwards Lifesciences Corporation Low-profile prosthetic heart valve for replacing a mitral valve
WO2016168609A1 (en) 2015-04-16 2016-10-20 Tendyne Holdings, Inc. Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
US10376364B2 (en) 2015-11-10 2019-08-13 Edwards Lifesciences Corporation Implant delivery capsule
US10470876B2 (en) 2015-11-10 2019-11-12 Edwards Lifesciences Corporation Transcatheter heart valve for replacing natural mitral valve
EP3377000B1 (en) 2015-11-17 2023-02-01 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
AU2016362474B2 (en) 2015-12-03 2021-04-22 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
JP6795591B2 (en) 2015-12-28 2020-12-02 テンダイン ホールディングス,インコーポレイテッド Atrial pocket closure for artificial heart valve
US10179043B2 (en) 2016-02-12 2019-01-15 Edwards Lifesciences Corporation Prosthetic heart valve having multi-level sealing member
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10517722B2 (en) 2016-03-24 2019-12-31 Edwards Lifesciences Corporation Delivery system for prosthetic heart valve
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
WO2017218375A1 (en) 2016-06-13 2017-12-21 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
EP3478224B1 (en) 2016-06-30 2022-11-02 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus for delivery of same
EP3484411A1 (en) 2016-07-12 2019-05-22 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
EP3848003A1 (en) 2016-08-10 2021-07-14 Cardiovalve Ltd. Prosthetic valve with concentric frames
EP3531978A4 (en) 2016-10-28 2020-06-03 Foldax, Inc. Prosthetic heart valves with elastic support structures and related methods
US10973631B2 (en) 2016-11-17 2021-04-13 Edwards Lifesciences Corporation Crimping accessory device for a prosthetic valve
US10463484B2 (en) 2016-11-17 2019-11-05 Edwards Lifesciences Corporation Prosthetic heart valve having leaflet inflow below frame
US10603165B2 (en) 2016-12-06 2020-03-31 Edwards Lifesciences Corporation Mechanically expanding heart valve and delivery apparatus therefor
US11654023B2 (en) 2017-01-23 2023-05-23 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11013600B2 (en) 2017-01-23 2021-05-25 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11185406B2 (en) 2017-01-23 2021-11-30 Edwards Lifesciences Corporation Covered prosthetic heart valve
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
WO2018148584A1 (en) 2017-02-10 2018-08-16 Millipede, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US11135056B2 (en) 2017-05-15 2021-10-05 Edwards Lifesciences Corporation Devices and methods of commissure formation for prosthetic heart valve
EP3630013A4 (en) 2017-05-22 2020-06-17 Edwards Lifesciences Corporation Valve anchor and installation method
US20210401571A9 (en) 2017-05-31 2021-12-30 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US10869759B2 (en) 2017-06-05 2020-12-22 Edwards Lifesciences Corporation Mechanically expandable heart valve
US11026785B2 (en) 2017-06-05 2021-06-08 Edwards Lifesciences Corporation Mechanically expandable heart valve
WO2019014473A1 (en) 2017-07-13 2019-01-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
US10918473B2 (en) 2017-07-18 2021-02-16 Edwards Lifesciences Corporation Transcatheter heart valve storage container and crimping mechanism
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
BR112020002459A2 (en) 2017-08-11 2020-07-28 Edwards Lifesciences Corporation sealing element for prosthetic heart valve
US11083575B2 (en) 2017-08-14 2021-08-10 Edwards Lifesciences Corporation Heart valve frame design with non-uniform struts
US10932903B2 (en) 2017-08-15 2021-03-02 Edwards Lifesciences Corporation Skirt assembly for implantable prosthetic valve
US10898319B2 (en) 2017-08-17 2021-01-26 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US10973628B2 (en) 2017-08-18 2021-04-13 Edwards Lifesciences Corporation Pericardial sealing member for prosthetic heart valve
US10722353B2 (en) 2017-08-21 2020-07-28 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
WO2019046099A1 (en) 2017-08-28 2019-03-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
US10973629B2 (en) 2017-09-06 2021-04-13 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US11147667B2 (en) 2017-09-08 2021-10-19 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
WO2019051476A1 (en) 2017-09-11 2019-03-14 Incubar, LLC Conduit vascular implant sealing device for reducing endoleak
AU2018334191B2 (en) 2017-09-12 2021-04-08 Edwards Lifesciences Corporation Leaflet frame attachment for prosthetic valves
CN111163728B (en) 2017-09-27 2022-04-29 W.L.戈尔及同仁股份有限公司 Prosthetic valve with mechanically coupled leaflets
CN111132636B (en) 2017-09-27 2022-04-08 W.L.戈尔及同仁股份有限公司 Prosthetic valves with expandable frames and associated systems and methods
EP3694445A1 (en) 2017-10-13 2020-08-19 W. L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
JP7052032B2 (en) 2017-10-31 2022-04-11 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド Medical valves and valve membranes that promote inward tissue growth
CA3078473C (en) 2017-10-31 2023-03-14 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
US11154397B2 (en) * 2017-10-31 2021-10-26 W. L. Gore & Associates, Inc. Jacket for surgical heart valve
JP7227240B2 (en) 2017-10-31 2023-02-21 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド artificial heart valve
CA3083533A1 (en) 2017-12-11 2019-06-20 California Institute Of Technology Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves
GB201720803D0 (en) 2017-12-13 2018-01-24 Mitraltech Ltd Prosthetic Valve and delivery tool therefor
GB201800399D0 (en) 2018-01-10 2018-02-21 Mitraltech Ltd Temperature-control during crimping of an implant
US11318011B2 (en) 2018-04-27 2022-05-03 Edwards Lifesciences Corporation Mechanically expandable heart valve with leaflet clamps
CN112867468A (en) 2018-10-19 2021-05-28 爱德华兹生命科学公司 Prosthetic heart valve with non-cylindrical frame
CN113164258A (en) 2018-11-01 2021-07-23 爱德华兹生命科学公司 Transcatheter regeneration pulmonary valve
USD926322S1 (en) 2018-11-07 2021-07-27 W. L. Gore & Associates, Inc. Heart valve cover
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
EP3946161A2 (en) 2019-03-26 2022-02-09 Edwards Lifesciences Corporation Prosthetic heart valve
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
EP4087501A4 (en) * 2020-02-18 2024-01-24 Lsi Solutions Inc Cardiac repair structure, apparatus, and methods thereof
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2822819A (en) 1953-08-07 1958-02-11 Geeraert Corp Cuspate check valve
US3548418A (en) 1968-05-03 1970-12-22 Cutter Lab Graft valve transplantation for human hearts and graft-support ring therefor
US3570014A (en) 1968-09-16 1971-03-16 Warren D Hancock Stent for heart valve
US3714671A (en) 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US3755823A (en) 1971-04-23 1973-09-04 Hancock Laboratories Inc Flexible stent for heart valve
US3744062A (en) 1971-10-08 1973-07-10 V Parsonnet Heart valve construction having a collagen cover encapsulation thereon
US4291420A (en) 1973-11-09 1981-09-29 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Artificial heart valve
US3983581A (en) 1975-01-20 1976-10-05 William W. Angell Heart valve stent
US4192020A (en) 1975-05-07 1980-03-11 Washington University Heart valve prosthesis
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
AR206762A1 (en) 1976-01-01 1976-08-13 Pisanu A LOW PROFILE BIOPROTHESIS DERIVED FROM PORCINE HETEROLOGICAL AORTIC VALVE
CA1069652A (en) 1976-01-09 1980-01-15 Alain F. Carpentier Supported bioprosthetic heart valve with compliant orifice ring
US4084268A (en) 1976-04-22 1978-04-18 Shiley Laboratories, Incorporated Prosthetic tissue heart valve
US4297749A (en) 1977-04-25 1981-11-03 Albany International Corp. Heart valve prosthesis
US4172295A (en) 1978-01-27 1979-10-30 Shiley Scientific, Inc. Tri-cuspid three-tissue prosthetic heart valve
US4247292A (en) 1979-06-06 1981-01-27 Angell William W Natural tissue heart valve fixation process
US4388735A (en) 1980-11-03 1983-06-21 Shiley Inc. Low profile prosthetic xenograft heart valve
EP0125393B1 (en) * 1980-11-03 1987-12-09 Shiley Incorporated Prosthetic heart valve
US4470157A (en) 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4501030A (en) 1981-08-17 1985-02-26 American Hospital Supply Corporation Method of leaflet attachment for prosthetic heart valves
DE3365190D1 (en) 1982-01-20 1986-09-18 Martin Morris Black Artificial heart valves
US4458570A (en) * 1982-01-25 1984-07-10 Marvin Glass & Associates Sheet material dispenser
GB8300636D0 (en) 1983-01-11 1983-02-09 Black M M Heart valve replacements
GB8424582D0 (en) 1984-09-28 1984-11-07 Univ Glasgow Heart valve prosthesis
CH672247A5 (en) 1986-03-06 1989-11-15 Mo Vysshee Tekhnicheskoe Uchil
US4725274A (en) 1986-10-24 1988-02-16 Baxter Travenol Laboratories, Inc. Prosthetic heart valve
US4851000A (en) 1987-07-31 1989-07-25 Pacific Biomedical Holdings, Ltd. Bioprosthetic valve stent
US5037434A (en) 1990-04-11 1991-08-06 Carbomedics, Inc. Bioprosthetic heart valve with elastic commissures
US5147391A (en) 1990-04-11 1992-09-15 Carbomedics, Inc. Bioprosthetic heart valve with semi-permeable commissure posts and deformable leaflets
US5755782A (en) 1991-01-24 1998-05-26 Autogenics Stents for autologous tissue heart valve
US5163955A (en) 1991-01-24 1992-11-17 Autogenics Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment
US5489298A (en) 1991-01-24 1996-02-06 Autogenics Rapid assembly concentric mating stent, tissue heart valve with enhanced clamping and tissue exposure
US5161955A (en) 1991-08-20 1992-11-10 Danielson Associates, Inc. High vacuum pump using bulk getter material
WO1994004099A1 (en) 1992-08-13 1994-03-03 Autogenics Tissue heart valve with concentric mating stents
GB9312666D0 (en) * 1993-06-18 1993-08-04 Vesely Ivan Bioprostetic heart valve
US5554673A (en) * 1993-11-29 1996-09-10 Polygenex International, Inc. Dip molded polyurethane film compositions
US5425741A (en) 1993-12-17 1995-06-20 Autogenics Tissue cutting die
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
WO1998025549A1 (en) * 1996-12-10 1998-06-18 Purdue Research Foundation Artificial vascular valves
US5928281A (en) * 1997-03-27 1999-07-27 Baxter International Inc. Tissue heart valves
US5935163A (en) * 1998-03-31 1999-08-10 Shelhigh, Inc. Natural tissue heart valve prosthesis
US6095968A (en) * 1998-04-10 2000-08-01 Cardio Technologies, Inc. Reinforcement device
US6254636B1 (en) * 1998-06-26 2001-07-03 St. Jude Medical, Inc. Single suture biological tissue aortic stentless valve

Cited By (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381218B2 (en) 2000-04-06 2008-06-03 Edwards Lifesciences Corporation System and method for implanting a two-part prosthetic heart valve
US6767362B2 (en) 2000-04-06 2004-07-27 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US20040186565A1 (en) * 2000-04-06 2004-09-23 Stefan Schreck Minimally-invasive heart valves with wireforms
US9439762B2 (en) 2000-06-01 2016-09-13 Edwards Lifesciences Corporation Methods of implant of a heart valve with a convertible sewing ring
US10238486B2 (en) 2000-06-01 2019-03-26 Edwards Lifesciences Corporation Heart valve with integrated stent and sewing ring
US20040138741A1 (en) * 2000-07-27 2004-07-15 Robert Stobie Heart valve holders and handling clips therefor
US7819915B2 (en) 2000-07-27 2010-10-26 Edwards Lifesciences Corporation Heart valve holders and handling clips therefor
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US8349003B2 (en) 2002-07-16 2013-01-08 Medtronic, Inc. Suture locking assembly and method of use
US20040210305A1 (en) * 2002-07-16 2004-10-21 Medtronic, Inc. Suture locking assembly and method of use
US8163008B2 (en) 2002-08-28 2012-04-24 Heart Leaflet Technologies, Inc. Leaflet valve
US20040127979A1 (en) * 2002-08-28 2004-07-01 Heart Leaflet Technologies, Inc Method of treating diseased valve
US7217287B2 (en) * 2002-08-28 2007-05-15 Heart Leaflet Technologies, Inc. Method of treating diseased valve
US8623080B2 (en) 2002-12-20 2014-01-07 Medtronic, Inc. Biologically implantable prosthesis and methods of using the same
US8460373B2 (en) 2002-12-20 2013-06-11 Medtronic, Inc. Method for implanting a heart valve within an annulus of a patient
US8025695B2 (en) 2002-12-20 2011-09-27 Medtronic, Inc. Biologically implantable heart valve system
US20040122516A1 (en) * 2002-12-20 2004-06-24 Fogarty Thomas J. Biologically implantable prosthesis and methods of using the same
US7981153B2 (en) 2002-12-20 2011-07-19 Medtronic, Inc. Biologically implantable prosthesis methods of using
US20050240263A1 (en) * 2002-12-20 2005-10-27 Fogarty Thomas J Biologically implantable prosthesis and methods of using the same
US9333078B2 (en) 2002-12-20 2016-05-10 Medtronic, Inc. Heart valve assemblies
US10595991B2 (en) 2002-12-20 2020-03-24 Medtronic, Inc. Heart valve assemblies
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US8747463B2 (en) 2003-08-22 2014-06-10 Medtronic, Inc. Methods of using a prosthesis fixturing device
US20050043760A1 (en) * 2003-08-22 2005-02-24 Fogarty Thomas J. Prosthesis fixturing device and methods of using the same
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US8603161B2 (en) 2003-10-08 2013-12-10 Medtronic, Inc. Attachment device and methods of using the same
US20100010616A1 (en) * 2003-10-08 2010-01-14 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
US10342661B2 (en) 2004-01-23 2019-07-09 Edwards Lifesciences Corporation Prosthetic mitral valve
US20110015731A1 (en) * 2004-01-23 2011-01-20 Edwards Lifesciences Corporation Anatomically Approximate Prosthetic Mitral Valve
US9155617B2 (en) 2004-01-23 2015-10-13 Edwards Lifesciences Corporation Prosthetic mitral valve
US7871435B2 (en) * 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
US9730794B2 (en) 2004-01-23 2017-08-15 Edwards Lifesciences Corporation Prosthetic mitral valve
US20060293745A1 (en) * 2004-01-23 2006-12-28 Carpentier Alain F Anatomically approximate prosthetic mitral heart valve
US8034104B2 (en) 2004-01-23 2011-10-11 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral valve
US10085836B2 (en) 2004-01-23 2018-10-02 Edwards Lifesciences Corporation Prosthetic mitral valve
US8721716B2 (en) 2004-01-23 2014-05-13 Edwards Lifesciences Corporation Prosthetic heart valve with dissimilar leaflets
US20050228494A1 (en) * 2004-03-29 2005-10-13 Salvador Marquez Controlled separation heart valve frame
US8574257B2 (en) 2005-02-10 2013-11-05 Edwards Lifesciences Corporation System, device, and method for providing access in a cardiovascular environment
US20100063363A1 (en) * 2005-02-10 2010-03-11 Hamman Baron L System, device, and method for providing access in a cardiovascular environment
US8500802B2 (en) 2005-04-08 2013-08-06 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US20110190877A1 (en) * 2005-04-08 2011-08-04 Medtronic, Inc. Two-Piece Prosthetic Valves with Snap-In Connection and Methods for Use
US20090192599A1 (en) * 2005-04-08 2009-07-30 Arbor Surgical Technologies, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US8911493B2 (en) 2005-05-24 2014-12-16 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valves
US9554903B2 (en) 2005-05-24 2017-01-31 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US20060287717A1 (en) * 2005-05-24 2006-12-21 Rowe Stanton J Methods for rapid deployment of prosthetic heart valves
US8500798B2 (en) 2005-05-24 2013-08-06 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US20060287719A1 (en) * 2005-05-24 2006-12-21 Rowe Stanton J Rapid deployment prosthetic heart valve
US10456251B2 (en) 2005-05-24 2019-10-29 Edwards Lifesciences Corporation Surgical methods of replacing prosthetic heart valves
US11284998B2 (en) 2005-05-24 2022-03-29 Edwards Lifesciences Corporation Surgical methods of replacing prosthetic heart valves
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
US10130468B2 (en) 2005-05-24 2018-11-20 Edwards Lifesciences Corporation Replacement prosthetic heart valves
US20070016285A1 (en) * 2005-05-27 2007-01-18 Ernest Lane Gasket with Collar for Prosthetic Heart Valves and Methods for Using Them
US8211169B2 (en) * 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US8506625B2 (en) 2005-07-13 2013-08-13 Edwards Lifesciences Corporation Contoured sewing ring for a prosthetic mitral heart valve
US20090209982A1 (en) * 2005-11-25 2009-08-20 Universitat Zurich Biodegradable Scaffold
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US20070225801A1 (en) * 2006-03-10 2007-09-27 Drews Michael J Valve introducers and methods for making and using them
US20070233228A1 (en) * 2006-03-28 2007-10-04 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US10058421B2 (en) 2006-03-28 2018-08-28 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US9331328B2 (en) 2006-03-28 2016-05-03 Medtronic, Inc. Prosthetic cardiac valve from pericardium material and methods of making same
US8821569B2 (en) 2006-04-29 2014-09-02 Medtronic, Inc. Multiple component prosthetic heart valve assemblies and methods for delivering them
US20070265701A1 (en) * 2006-04-29 2007-11-15 Gurskis Donnell W Multiple component prosthetic heart valve assemblies and apparatus for delivering them
US20070288089A1 (en) * 2006-04-29 2007-12-13 Gurskis Donnell W Multiple component prosthetic heart valve assemblies and methods for delivering them
US20070254273A1 (en) * 2006-05-01 2007-11-01 Hugues Lafrance Simulated heart valve root for training and testing
US8021161B2 (en) 2006-05-01 2011-09-20 Edwards Lifesciences Corporation Simulated heart valve root for training and testing
US9314334B2 (en) 2008-11-25 2016-04-19 Edwards Lifesciences Corporation Conformal expansion of prosthetic devices to anatomical shapes
US10667906B2 (en) 2008-11-25 2020-06-02 Edwards Lifesciences Corporation Methods of conformal expansion of prosthetic heart valves
US9561100B2 (en) 2008-12-19 2017-02-07 Edwards Lifesciences Corporation Systems for quickly delivering a prosthetic heart valve
US10182909B2 (en) 2008-12-19 2019-01-22 Edwards Lifesciences Corporation Methods for quickly implanting a prosthetic heart valve
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US10799346B2 (en) 2008-12-19 2020-10-13 Edwards Lifesciences Corporation Methods for quickly implanting a prosthetic heart valve
US9005278B2 (en) 2008-12-19 2015-04-14 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve
US11504232B2 (en) 2008-12-19 2022-11-22 Edwards Lifesciences Corporation Rapid implant prosthetic heart valve system
US9931207B2 (en) 2009-03-31 2018-04-03 Edwards Lifesciences Corporation Methods of implanting a heart valve at an aortic annulus
US10842623B2 (en) 2009-03-31 2020-11-24 Edwards Lifesciences Corporation Methods of implanting prosthetic heart valve using position markers
US20100249894A1 (en) * 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
US9248016B2 (en) 2009-03-31 2016-02-02 Edwards Lifesciences Corporation Prosthetic heart valve system
US20100249908A1 (en) * 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US10555810B2 (en) 2009-06-26 2020-02-11 Edwards Lifesciences Corporation Prosthetic heart valve deployment systems
US9005277B2 (en) 2009-06-26 2015-04-14 Edwards Lifesciences Corporation Unitary quick-connect prosthetic heart valve deployment system
US8696742B2 (en) 2009-06-26 2014-04-15 Edwards Lifesciences Corporation Unitary quick-connect prosthetic heart valve deployment methods
US20110098602A1 (en) * 2009-10-27 2011-04-28 Edwards Lifesciences Corporation Apparatus and Method for Measuring Body Orifice
US10231646B2 (en) 2009-10-27 2019-03-19 Edwards Lifesciences Corporation Device for measuring an aortic valve annulus in an expanded condition
US8449625B2 (en) 2009-10-27 2013-05-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US9603553B2 (en) 2009-10-27 2017-03-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US11412954B2 (en) 2009-10-27 2022-08-16 Edwards Lifesciences Corporation Device for measuring an aortic valve annulus in an expanded condition
US8986374B2 (en) 2010-05-10 2015-03-24 Edwards Lifesciences Corporation Prosthetic heart valve
US10702383B2 (en) 2010-05-10 2020-07-07 Edwards Lifesciences Corporation Methods of delivering and implanting resilient prosthetic surgical heart valves
US11571299B2 (en) 2010-05-10 2023-02-07 Edwards Lifesciences Corporation Methods for manufacturing resilient prosthetic surgical heart valves
US10463480B2 (en) 2010-05-12 2019-11-05 Edwards Lifesciences Corporation Leaflet for low gradient prosthetic heart valve
US9554901B2 (en) 2010-05-12 2017-01-31 Edwards Lifesciences Corporation Low gradient prosthetic heart valve
US11266497B2 (en) 2010-05-12 2022-03-08 Edwards Lifesciences Corporation Low gradient prosthetic heart valves
US10722358B2 (en) 2010-09-10 2020-07-28 Edwards Lifesciences Corporation Systems for rapidly deployable surgical heart valves
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
US11197757B2 (en) 2010-09-10 2021-12-14 Edwards Lifesciences Corporation Methods of safely expanding prosthetic heart valves
US9968450B2 (en) 2010-09-10 2018-05-15 Edwards Lifesciences Corporation Methods for ensuring safe and rapid deployment of prosthetic heart valves
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US11775613B2 (en) 2010-09-10 2023-10-03 Edwards Lifesciences Corporation Methods of safely expanding prosthetic heart valves
US10039641B2 (en) 2010-09-10 2018-08-07 Edwards Lifesciences Corporation Methods of rapidly deployable surgical heart valves
US11471279B2 (en) 2010-09-10 2022-10-18 Edwards Lifesciences Corporation Systems for rapidly deployable surgical heart valves
US9504563B2 (en) 2010-09-10 2016-11-29 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US10548728B2 (en) 2010-09-10 2020-02-04 Edwards Lifesciences Corporation Safety systems for expansion of prosthetic heart valves
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US11207178B2 (en) 2010-09-27 2021-12-28 Edwards Lifesciences Corporation Collapsible-expandable heart valves
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
US10736741B2 (en) 2010-09-27 2020-08-11 Edwards Lifesciences Corporation Methods of delivery of heart valves
US9861479B2 (en) 2010-09-27 2018-01-09 Edwards Lifesciences Corporation Methods of delivery of flexible heart valves
US10543080B2 (en) 2011-05-20 2020-01-28 Edwards Lifesciences Corporation Methods of making encapsulated heart valves
US11517426B2 (en) 2011-05-20 2022-12-06 Edwards Lifesciences Corporation Encapsulated heart valves
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US10849752B2 (en) 2011-12-21 2020-12-01 Edwards Lifesciences Corporation Methods for anchoring a device at a native heart valve annulus
US11452602B2 (en) 2011-12-21 2022-09-27 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a native heart valve annulus
US10238489B2 (en) 2011-12-21 2019-03-26 Edwards Lifesciences Corporation Anchoring device and method for replacing or repairing a heart valve
US10058425B2 (en) 2013-03-15 2018-08-28 Edwards Lifesciences Corporation Methods of assembling a valved aortic conduit
US11648116B2 (en) 2013-03-15 2023-05-16 Edwards Lifesciences Corporation Methods of assembling valved aortic conduits
US11007058B2 (en) 2013-03-15 2021-05-18 Edwards Lifesciences Corporation Valved aortic conduits
US9968451B2 (en) 2013-06-12 2018-05-15 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US11464633B2 (en) 2013-06-12 2022-10-11 Edwards Lifesciences Corporation Heart valve implants with side slits
US10314706B2 (en) 2013-06-12 2019-06-11 Edwards Lifesciences Corporation Methods of implanting a cardiac implant with integrated suture fasteners
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
US10702680B2 (en) 2013-08-28 2020-07-07 Edwards Lifesciences Corporation Method of operating an integrated balloon catheter inflation system
US11266499B2 (en) 2013-09-20 2022-03-08 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US10441415B2 (en) 2013-09-20 2019-10-15 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US10722316B2 (en) 2013-11-06 2020-07-28 Edwards Lifesciences Corporation Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage
US9549816B2 (en) 2014-04-03 2017-01-24 Edwards Lifesciences Corporation Method for manufacturing high durability heart valve
US11376122B2 (en) 2014-04-30 2022-07-05 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US10307249B2 (en) 2014-04-30 2019-06-04 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US10130469B2 (en) 2014-06-20 2018-11-20 Edwards Lifesciences Corporation Expandable surgical heart valve indicators
US11154394B2 (en) 2014-06-20 2021-10-26 Edwards Lifesciences Corporation Methods of identifying and replacing implanted heart valves
US9504566B2 (en) 2014-06-20 2016-11-29 Edwards Lifesciences Corporation Surgical heart valves identifiable post-implant
USD893031S1 (en) 2015-06-19 2020-08-11 Edwards Lifesciences Corporation Prosthetic heart valve
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
US10695170B2 (en) 2015-07-02 2020-06-30 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US11654020B2 (en) 2015-07-02 2023-05-23 Edwards Lifesciences Corporation Hybrid heart valves
US10456246B2 (en) 2015-07-02 2019-10-29 Edwards Lifesciences Corporation Integrated hybrid heart valves
US11690714B2 (en) 2015-07-02 2023-07-04 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US11690709B2 (en) 2015-09-02 2023-07-04 Edwards Lifesciences Corporation Methods for securing a transcatheter valve to a bioprosthetic cardiac structure
US10751174B2 (en) 2015-09-10 2020-08-25 Edwards Lifesciences Corporation Limited expansion heart valve
US10080653B2 (en) 2015-09-10 2018-09-25 Edwards Lifesciences Corporation Limited expansion heart valve
US11806232B2 (en) 2015-09-10 2023-11-07 Edwards Lifesciences Corporation Limited expansion valve-in-valve procedures
US10667904B2 (en) 2016-03-08 2020-06-02 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
US11471275B2 (en) 2016-03-08 2022-10-18 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
US11376125B2 (en) 2017-04-06 2022-07-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
US10463485B2 (en) 2017-04-06 2019-11-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
US10799353B2 (en) 2017-04-28 2020-10-13 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
US11911273B2 (en) 2017-04-28 2024-02-27 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
US11135057B2 (en) 2017-06-21 2021-10-05 Edwards Lifesciences Corporation Dual-wireform limited expansion heart valves
US11337805B2 (en) 2018-01-23 2022-05-24 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
USD995774S1 (en) 2018-07-11 2023-08-15 Edwards Lifesciences Corporation Collapsible heart valve sizer
USD952143S1 (en) 2018-07-11 2022-05-17 Edwards Lifesciences Corporation Collapsible heart valve sizer
US11554012B2 (en) 2019-12-16 2023-01-17 Edwards Lifesciences Corporation Valve holder assembly with suture looping protection

Also Published As

Publication number Publication date
AU6259499A (en) 2000-04-17
EP1117354A1 (en) 2001-07-25
WO2000018333A1 (en) 2000-04-06
US6334873B1 (en) 2002-01-01
CN1328436A (en) 2001-12-26
JP2002525169A (en) 2002-08-13

Similar Documents

Publication Publication Date Title
US6334873B1 (en) Heart valve having tissue retention with anchors and an outer sheath
US10010413B2 (en) Prosthetic heart valve including stent structure and tissue leaflets, and related methods
US10238486B2 (en) Heart valve with integrated stent and sewing ring
US6270527B1 (en) Elastic valve with partially exposed stent
EP0705081B1 (en) Stented bioprosthetic heart valve
US6371983B1 (en) Bioprosthetic heart valve
JP4230118B2 (en) Flexible heart valve
US5489298A (en) Rapid assembly concentric mating stent, tissue heart valve with enhanced clamping and tissue exposure
US5662705A (en) Test device for and method of testing rapid assembly tissue heart valve
EP1429690B1 (en) Low-profile heart valve sewing ring
US20030167089A1 (en) Bioprosthetic heart valve
US11007058B2 (en) Valved aortic conduits
WO1994004099A1 (en) Tissue heart valve with concentric mating stents
AU2001293104A1 (en) Low-profile heart valve sewing ring

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION